Inventor · disambiguated record
Yuandong Hu
Also filed as: HU YUANDONG
15 granted patents·1 pending application·77 citations·filing 2011–2017
89Inventor score
Top patents by PatentIndex Score
16 records- 0192US9725439B2Quinazoline derivative and preparation method thereforCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2014·Granted Aug 8, 2017·13 cites·16 claims
- 0290US9926299B2Inhibitors of bruton's tyrosine kinaseCENTAURUS BIOPHARMA CO LTD·Filed 2013·Granted Mar 27, 2018·33 cites·9 claims
- 0385US9309211B2Arylalkene derivatives and use thereof as selective estrogen receptor modulatorsCENTAURUS BIOPHARMA CO LTD·Filed 2012·Granted Apr 12, 2016·11 cites·6 claims
- 0483US10561657B2Pyrrolopyrimidine compoundCENTAURUS BIOPHARMA CO LTD·Filed 2015·Granted Feb 18, 2020·3 cites·19 claims
- 0582US9550781B2Kinase modulating compounds, compositions containing the same and use thereofCENTAURUS BIOPHARMA CO LTD·Filed 2012·Granted Jan 24, 2017·9 cites·14 claims
- 0679US10745383B21,3,5-triazine derivative and method of using sameCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2016·Granted Aug 18, 2020·2 cites·15 claims
- 0773US9708295B2Substituted 2-aminopyridine protein kinase inhibitorCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2014·Granted Jul 18, 2017·3 cites·17 claims
- 0870US10570141B2Substituted pyrrolopyrimidine CDK inhibitor, pharmaceutical composition containing same and use thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2017·Granted Feb 25, 2020·1 cites·20 claims
- 0964US9428508B22,4-diamino-6,7-dihydro-5H-pyrrolo[2,3]pyrimidine derivatives as FAK/Pyk2 inhibitorsXIAO DENGMING·Filed 2012·Granted Aug 30, 2016·2 cites·3 claims
- 1055US10329277B2N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(3-methyl-2-OXO-2,3-dihydro-1h-benzo[d]imidazol-1-yl)pyrimidin-2-yl)amino)phenyl)acrylamide hydrochloride as an inhibitor of epidermal growth factor receptor activityCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2016·Granted Jun 25, 2019·0 cites·7 claims
- 1144US11203586B2Iridinesulfonamide compound and use method thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2017·Granted Dec 21, 2021·0 cites·16 claims
- 1242US11111240B2Sultam compound and application method thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2017·Granted Sep 7, 2021·0 cites·20 claims
- 1340US10155722B2Antitumor compound targeting IDH2 mutation and method of use thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2016·Granted Dec 18, 2018·0 cites·20 claims
- 1439US10829492B2Amino pyrazolopyrimidine compound used as neurotrophic factor tyrosine kinase receptor inhibitorCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2017·Granted Nov 10, 2020·0 cites·20 claims
- 1533US9540396B26-arylamino pyridone carboxamide as MEK inhibitorsXIAO DENGMING·Filed 2011·Granted Jan 10, 2017·0 cites·10 claims
- 1632US2014018380A1Bicyclic heteroaryl compounds as gpr119 receptor agonistsXIAO DENGMING·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →